Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

AI startup Carenostics raises $5 million in Seed funding led by M13 to transform healthcare through earlier diagnosis and treatment of chronic disease patients


News provided by

Carenostics

Sep 14, 2023, 10:00 ET

Share this article

Share toX

Share this article

Share toX


Carenostics brings together the first team to ever deploy AI at 1,000+ health systems to now tackle the underdiagnosis, undertreatment, and health inequities of chronic disease.

NEW YORK, Sept. 14, 2023 /PRNewswire-PRWeb/ -- Carenostics, a pioneering healthcare AI startup tackling undiagnosed and undertreated chronic disease, has successfully closed a $5 million seed funding round led by M13. Other participants in the round include Greatpoint Ventures, Gaingels, and Kurt Hilzinger, Chairman of Humana, who also joined Carenostics' advisory board.

The US healthcare system is plagued by chronic disease, which is the leading cause of death and disability in the US and drains a staggering 90% of the roughly $4.1 trillion in annual healthcare spend. A significant portion of these outcomes and expenses are driven by undiagnosed chronic disease patients being treated too late - with certain conditions, like chronic kidney disease (CKD), estimated to be 80% undiagnosed.

Carenostics, a pioneering healthcare AI startup tackling undiagnosed and undertreated chronic disease, has successfully closed a $5 million seed funding round led by M13.

Post this

A contributing factor to late diagnosis and treatment is overburdened physicians; a recent study from the Journal of General Internal Medicine showed that it would take 27 hours each day for a doctor to follow all acute, chronic and preventive guidelines.

These gaps in healthcare became deeply personal for Kanishka Rao, Carenostics' Co-founder and COO, when his grandfather succumbed to previously undiagnosed CKD. Carenostics was founded in response to this tragedy.

Carenostics has developed a revolutionary AI platform that identifies undiagnosed and undertreated chronic disease patients and prompts clinicians within their current workflows to intervene earlier. The platform uniquely tailors AI models to each health system using existing, local electronic health record (EHR) data, and supports physicians across multiple diseases. The platform prioritizes patient data privacy, ensuring no information ever leaves the hospital system.

Carenostics has been deployed at leading health systems including Hackensack Meridian Health, the largest hospital system in the state of New Jersey with 18 hospitals and 6 million patient records, to support physicians across an array of chronic conditions.

At Hackensack, Carenostics' platform has identified up to 3x more chronic kidney disease (CKD) patients and up to 20x more severe and uncontrolled asthma (SUA) patients, while maintaining a 5x lower false positive rate than current care practices. Carenostics has integrated AI insights into existing clinical workflows, demonstrating clinician activation rates up to 5x higher than industry benchmarks.

In addition to Hackensack, Carenostics' partnerships include AstraZeneca, the VA, and a partnership and investment from Bayer G4A (Bayer's only early-stage investment of 2022).

Kanishka and his father Dr. Bharat Rao, Co-Founder and CEO of Carenostics, form the core of Carenostics' veteran leadership team. The team includes more than five AI PhDs; leaders from Siemens, McKinsey, ConcertAI, Cerner, and Amazon; and the team that previously developed the world's first AI and natural language processing (NLP) solution deployed within EHRs at 300+ health systems.

"Bharat and Kanishka have assembled a world-class leadership team of AI pioneers that were the first to deploy AI at scale on EHR data," stated Latif Peracha, General Partner at M13. "The future of healthcare is proactive, not reactive, and Carenostics's use of clinical AI holds the transformative power to overhaul our industry by tackling the costly and life-threatening delays in diagnosis and treatment."

Dr. Rao said, "We are setting the stage for a data-driven healthcare revolution, where every diagnostic and treatment decision is personalized using patient data and AI." He holds a PhD in AI, and previously led Healthcare AI for Siemens and KPMG's US Healthcare & Life Sciences AI & Analytics practice. Notable achievements include the deployment of 20+ FDA- and EU-approved healthcare AI products in 1,000+ global health systems, 150+ peer-reviewed publications, and 60+ AI patents.

Carenostics is also announcing the formation of its advisory board of industry leaders including Kurt Hilzinger, the Chairman of Humana; Dr. John Glaser, former CEO of Siemens Health Services & CIO of Partners Healthcare; Aneesh Chopra, the former Chief Technology Officer of the United States; and Professor Srini Devadas, former associate department chair of Computer Science at MIT.

Carenostics will use its funding to accelerate expansion to many more health systems and chronic conditions.

"Our goal is to stop the story of my grandfather from repeating itself, ultimately improving healthcare outcomes and reducing costs," said Kanishka Rao. Prior to Carenostics, Rao was a healthtech strategist and led McKinsey's US Healthcare Startups practice.

For more information, visit https://www.carenostics.com/.

About Carenostics

Carenostics revolutionizes patient care through the application of clinically-oriented artificial intelligence which identifies patients at risk for chronic diseases. The company's cutting-edge platform seamlessly integrates into clinicians' workflow leading to faster, earlier diagnosis and treatment for a much greater number of patients.The result is improved patient outcomes and enhanced healthcare efficiency. Carenostics has received awards from Bio-IT World, the National Science Foundation, and the Digital Health Hub Foundation, and their work has been accepted for publication in NeurIPS and AMGA.

For more information, visit https://www.carenostics.com/.

Media Contact

Kanishka Rao, Carenostics, 1 9175355945, [email protected], carenostics.com

SOURCE Carenostics

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.